Characteristic expression of thrombomodulin in the muscle sarcoplasm in patients with the acute phase of rhabdomyolysis

European Neurology

Volumn 43, Issue 3, 2000, Pages 174-180

  Hu, Jing ^a   Higuchi, Itsuro ^a   Inose, Masaru ^a   Niiyama, Takahito ^a   Uchida, Yuichi ^a   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Degeneration; Malignant hyperthermia; Neural cell adhesion molecule; Regeneration; Rhabdomyolysis; Thrombomodulin

Indexed keywords

NERVE CELL ADHESION MOLECULE; THROMBOMODULIN;

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; BLOOD VESSEL WALL; CHILD; CLINICAL ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; ELECTRON MICROSCOPY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; MUSCLE FIBER MEMBRANE; MYOPATHY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOLYSIS; SARCOLEMMA; SARCOPLASM;

EID: 0034027255     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008159     Document Type: Article

References (24)

1. Maruyama I, Bell E, Majerus PW: Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 1985;101:363-371.
2. Salem HH, Maruyama I, Ishii H, Majerus PW: Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 1984; 259:12246-12251.
3. Yonezawa S, Maruyama I, Sakae K, Igata A, Majerus PW, Sato E: Thrombomodulin as a marker for vascular tumors; comparative study with factor VIII and Ulex europacus I lectin. Am J Clin Pathol 1987;88:405-411.
4. Imada M, Imada S, Iwasaki H, Kume A, Yamaguchi H, Moore EE: Fetomodulin: Marker surface protein of fetal development which is modulatable by cyclin AMP. Dev Biol 1987; 122:483-491.
5. Imada S. Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M: Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 1990; 140:113-122.
6. McCachren SS, Diggs J, Weinberg JB, Dittman WA: Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 1991;78:3128-3132.
7. Niiyama T, Higuchi I, Osame M, Maruyama I: Expression of thrombomodulin, caveolin-3 and desmin on muscle fibers in neuromuscular diseases. Muscle Nerve 1999;22:1713-1716.
8. Higuchi I, Niiyama T, Uchida Y, Inose M, Nakagawa M, Arimura K, Osame M: Multiple episodes of thrombosis in a patient with Becker muscular dystrophy with marked expression of utrophin on the muscle cell membrane. Acta Neuropathol 1999;98:313-316.
9. Esmon CT, Esmon NL, Harris KW: Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982;257:7944-7947.
10. Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S: A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 1989;264:4872-4876.
11. Rutishauser U: Developmental biology of the neural cell adhesion molecule. Nature 1984; 310:549-554.
12. Williams AF, Barclay AN: The immunoglobulin super family - Domains for cell surface recognition. Annu Rev Immunol 1988;6:381-405.
13. Figarella-Branger D, Nedelac J, Pellissier JF, Boucraut J, Bianco N, Rougon G: Expression of various isoforms of neural cell adhesive molecules and their highly polysialylated counterparts in diseased human muscles. J Neurol Sci 1990;98:21-36.
14. Illa I, Leon-Monzon M, Dalakas MC: Regenerating and denervatcd human muscle fibers and satellite cells express neuronal cell adhesion molecule recognized by monoclonal antibodies to natural killer cell. Ann Neurol 1992;31:46-52.
15. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
16. Higuchi I. Fukunaga H, Motokura F, Niiyama T, Inose M, Izumi K. Ohkuba R, Nakagawa M, Arimura K, Osame M: Characteristic expression of cell adhesion molecules in adhalin deficiency. J Neurol Sci 1996;143:79-83.
17. Rosenberg H: Clinical presentation of malignant hyperthermia. Br J Anaesthesiol 1988;60: 268-273.
18. Schicha H, Rumpf KW, Kaiser H, Emrich D: Scintigraphy with 99mTc-methylene disphosphonate for the detection and localization of rhabdomyolysis. Nuklearmedizin 1984;23: 287-291 (in German).
19. Kendrick WC, Hull AR, Knochel JP: Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 1977; 86:381-387.
20. Koppes GM, Daly JJ, Coltman CA Jr, Butkus DE: Exertion-induced rhabdomyolysis with acute renal failure and disseminated intravascular coagulation in sickle cell trait. Am J Med 1977;63:313-317.
21. Willner JH, Cerri CG, Wood DS: High skeletal muscle adenylate cyclase in malignant hyperthermia. J Clin Invest 1981;68:1119-1124.
22. Ollivier V, Houssaye S, Ternisien C, Leon A, de Verneuil H, Elbim C, Mackman N, Edgington TS, de Prost D: Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 1993;81:973-979.
23. Guttridge DC, Lau A, Tran L, Cunningham DD: Thrombin causes a marked delay in skeletal myogenesis that correlates with the delayed expression of myogenin and p21CIP1/WAF1. J Biol Chem 1997;272:24117-24120.
24. Gullotta F, Helpap B: Histological, histochemical, and ultrastructural findings in malignant hyperthermia. Virchows Arch A Pathol Anat Histol 1975;367:181-194.